Navigation Links
XTENT Announces Second Quarter 2008 Financial Results and Business Progress
Date:8/6/2008

MENLO PARK, Calif., Aug. 6 /PRNewswire-FirstCall/ -- XTENT, Inc. (Nasdaq: XTNT) today reported financial results for the second quarter and six months ended June 30, 2008 and provided an update on its business.

The company reported a net loss of $12.9 million, or $0.56 per share, for the second quarter of 2008, compared to a net loss of $9.5 million, or $0.42 per share, for the second quarter of 2007. The company's net loss for the second quarter of 2008 was based on weighted average shares outstanding of 23.0 million as compared to 22.6 million weighted average shares outstanding for the second quarter of 2007. For the six months ended June 30, 2008, XTENT had a net loss of $25.3 million, compared to $17.4 million for the same period last year. As of June 30, 2008, XTENT had cash, cash equivalents and short-term investments of $34.4 million.

Research and development expenses increased to $9.8 million in the second quarter of 2008 from $7.7 million for the same period in 2007, primarily due to an increased number of research and development personnel, expenditures for prototype parts and supplies as well as costs incurred for clinical trials. General and administrative expenses were $3.3 million in the second quarter of 2008 versus $2.8 million for the same period in 2007, primarily due to an increase in personnel costs related to the hiring of additional employees as well as consulting, legal, professional services and other administrative costs associated with operating as a public company. Research and development expenses for the six month period ended June 30, 2008 totaled $19.2 million, compared to $13.9 million for the same period last year. General and administrative expenses for the six months ended June 30, 2008 to
'/>"/>

SOURCE XTENT, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. XTENT Appoints Christopher M. Smith and Arthur T. Taylor to Board of Directors
2. XTENT Announces CUSTOM I Data Receives Recognition from EuroIntervention
3. XTENT to Present at Cowen and Companys 28th Annual Health Care Conference
4. XTENT Announces 2007 Financial Results
5. New study shows extent of harmful human influences on global ecosystems
6. XTENT Announces 2007 Financial Results Conference Call
7. XTENT Submits CE Mark Registration to Market Custom NX(R) Drug-Eluting Stent System in Europe
8. XTENT Announces Third Quarter 2007 Financial Results
9. eDiets.com(R) Announces Q2 2008 Results
10. CPI International Announces Third Quarter 2008 Financial Results
11. MedQuist Announces Changes to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... ... 2015 , ... “Engage: Don’t Just Age” will be the ... symposiums, hosted by Massachusetts-based Harmony Healthcare International at Foxwoods Resort Casino in ... executives, administrators, directors of nursing, rehabilitation managers and other management and corporate personnel ...
(Date:7/31/2015)... Seattle, WA (PRWEB) , ... July 31, 2015 , ... ... rapidly transforming the way we treat aging diseases. , BioViva announces it has ... to treat patients with Alzheimer’s Disease (AD) and find a cure. MaxLife will grant ...
(Date:7/31/2015)... ... , ... The alarm was ringing. Hugh Chatfield, survivor of a severe 1987 brain injury, almost ... his equipment was set up to depict the newly poured concrete. With a clear view ... photo speaks for itself. Chatfield is also a highly praised safety and drug education speaker/comedian. ...
(Date:7/31/2015)... ... ... Awarded to only the Top 10 hair transplant practices in the United ... recipients of the Center of Clinical Excellence for ARTAS Robotic Hair Transplantation . ... science of hair transplant. , Parsa Mohebi Hair Restoration is known worldwide for their ...
(Date:7/31/2015)... (PRWEB) , ... July 31, 2015 , ... ... selected as a contributor for LeadingAge’s Center for Aging Services Technologies (CAST) Medication ... to help long-term and post-acute care providers understand the benefits of using ...
Breaking Medicine News(10 mins):Health News:Harmony Healthcare International Announces Speaker Line-up for “HARMONY 2015” 2Health News:Harmony Healthcare International Announces Speaker Line-up for “HARMONY 2015” 3Health News:BioViva USA, Inc.’s Alzheimer’s Disease Gene Therapy Human Trial 2Health News:BioViva USA, Inc.’s Alzheimer’s Disease Gene Therapy Human Trial 3Health News:Prestigious Medical Award Given To Parsa Mohebi Hair Restoration for Excellence in Hair Transplantation 2Health News:LeadingAge Selects Eldermark Case Study to Highlight Medication Error Reduction Results 2Health News:LeadingAge Selects Eldermark Case Study to Highlight Medication Error Reduction Results 3
... the Wall Street Journal and Congressional,Quarterly to Head Kaiser ... to Readers and News,Organizations, MENLO PARK, Calif., Oct. ... News (KHN), an independent,news service, to report on the ... and policy debates surrounding it., The goal of ...
... Morria Biopharmaceuticals Plc, a,biopharmaceutical company focused ... today the preliminary results from its,recently completed ... a nasal aerosol,formulation, in 105 patients suffering ... double-blind, placebo-controlled study,included Rhinocort(R) as the steroid ...
... Helen eWard; Dynamic Site Drives Fight Against Childhood,Obesity by ... DETROIT, Oct. 29 Troy (Mich.) Chamber of ... Helen eWards,for Web Excellence, sponsored by Miller Canfield. The ... selected as the best site in the,Social Impact category ...
... genome has opened the door for proteomics by providing ... there is intense interest in applying proteomics to foster ... for diagnosis and early detection of cancer. Gastric carcinoma ... is the most common cause of cancer-related death in ...
... Abbott (NYSE: ABT ),will present at the 17th ... Thomas C. Freyman, executive vice president, finance,and chief financial ... 5,p.m. CST., A live audio webcast of the ... at http://www.abbottinvestor.com . An,archived edition of the presentation ...
... Berger & Montague,("Berger") announced today that a class action ... New York on behalf of all purchasers of,American Depository ... ("elan" or the "Company") and all purchasers of,options to ... 2008,through July 29, 2008 (the "Class Period") charging Elan ...
Cached Medicine News:Health News:Kaiser Family Foundation to Launch Non-Profit Health Policy News Service 2Health News:Kaiser Family Foundation to Launch Non-Profit Health Policy News Service 3Health News:Morria Biopharmaceuticals Plc Announces Preliminary Results Regarding Inflammatory Markers From its Phase II Study in Allergic Rhinitis 2Health News:Danialle Karmanos' Work It Out (DKWIO) Site Earns Recognition for Web Excellence 2Health News:Berger & Montague Announces Class Action Lawsuit Against Elan Corporation 2Health News:Berger & Montague Announces Class Action Lawsuit Against Elan Corporation 3Health News:Berger & Montague Announces Class Action Lawsuit Against Elan Corporation 4
(Date:7/31/2015)... 2015  Seeger Weiss LLP is reporting that on July ... letter to C.R. Bard, the manufacturer of Inferior vena ... correct violations the agency found at two of Bard,s facilities. ... FDA cited them during Inspectional Observations that occurred on November ... Tempe, AZ , location and on October 6, 2014, ...
(Date:7/31/2015)... RnRMarketResearch.com adds Syringes and ... that provides an overview of syringes and needles ... in-house databases, secondary and primary research. ... pipeline spread across 124 pages, talking about 13 ... 5 figures is now available at http://www.rnrmarketresearch.com/syringes-and-needles-pipeline-review-2015-market-report.html ...
(Date:7/31/2015)... According to a new market research report " Sterilization ... Filtration, E-beam, Gamma), Services (Onsite & Offsite), Consumables (Indicators, Detergents, ... 2020", published by MarketsandMarkets, The Sterilization Equipment Market is expected ... CAGR of 7.6%.from 2015 to 2020. Browse ... and 37 F igures spread ...
Breaking Medicine Technology:Seeger Weiss LLP Reports That The FDA Has Issued A Warning Letter To IVC Filter Manufacturer, C.R. Bard 2Seeger Weiss LLP Reports That The FDA Has Issued A Warning Letter To IVC Filter Manufacturer, C.R. Bard 3Syringes and Needles Market Products Pipeline Review 2015 Report 2Syringes and Needles Market Products Pipeline Review 2015 Report 3Syringes and Needles Market Products Pipeline Review 2015 Report 4Syringes and Needles Market Products Pipeline Review 2015 Report 5Sterilization Equipment Market is Expected to Reach USD 6.1 Billion by 2020 2Sterilization Equipment Market is Expected to Reach USD 6.1 Billion by 2020 3Sterilization Equipment Market is Expected to Reach USD 6.1 Billion by 2020 4
... NEW BRUNSWICK, N.J., Jan. 14, 2011 McNeil Consumer Healthcare ... JNJ ) company, in July 2010 submitted to the ... a commitment to restore its operations to the level of ... Johnson companies. As part of this commitment, McNeil undertook a ...
... 2011 New clinical research data suggests that [18F] ... by physicians and provide accurate identification of beta amyloid ... to Alzheimer,s Disease (AD).  Flutemetamol, a GE Healthcare Positron ... development, is being studied to identify the uptake of ...
Cached Medicine Technology:Johnson & Johnson Provides Update on McNeil Consumer Healthcare Remediation; Announces Completion of Internal Assessment Phase of Comprehensive Action Plan 2GE Healthcare Presents Flutemetamol Data for Detection of Amyloid Plaque Linked to Alzheimer's Disease 2GE Healthcare Presents Flutemetamol Data for Detection of Amyloid Plaque Linked to Alzheimer's Disease 3
6 inch hand held occlcuder with 49 holes...
Designed to provide occlusion while permitting observation of the eye. Helpful to determine if only one eye is deviating. Approximately 9 inches long....
Short handle occluders are about 6 inches long....
Manual Lensmeter....
Medicine Products: